South Texas Alzheimer's Conference
Health care professionals and students are invited to join world renown experts for collaboration and discussion on transformational care, research and therapeutics in Alzheimer’s disease.
About the conference
Health care professionals and students interested in collaboration and discussion on transformational care, research and therapeutics in Alzheimer’s disease are invited to our annual South Texas Alzheimer’s Conference. The annual conference is presented by the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases in partnership with the Alzheimer's Association. 2020 conference theme:- Alzheimer’s in the Hispanic Population
- Precision Omics, Cognitive and Neuroimaging Approach to the Diagnosis, Prevention and Treatment of Dementia
- Novel Approaches to the Care and Treatment of Patients and Care Partners Including Home Based Care
Event schedule
Pre-Conference Public Event and Opening Reception
Pre-Conference Public Event
Members of the community and conference attendees are invited to meet renowned experts in dementia care and hear a panel discussion on new therapies for Alzheimer’s disease and other dementias as part of the South Texas Alzheimer’s Conference Public Event.
Featured Topic: “New Hope for Treating and Preventing Alzheimer’s and Other Dementias: Discoveries from Around the World”
Location
UT Health San Antonio Holly Auditorium, 7703 Floyd Curl Drive, San Antonio, TX 78229
Opening Reception
Conference attendees are invited to join us for networking, dinner and presentations.
Location
UT Health San Antonio Academic Learning and Teaching Center, 3rd Floor, 703 Floyd Curl Drive, San Antonio, TX 78229
Welcome Remarks
Sudha Seshadri, M.D.
Presentations
Plenary: “Dementia Research in a Humanitarian Crisis Setting,” Gladys E. Maestre, M.D., Ph.D.
“New Approaches to Care and Treatments for Alzheimer’s Disease,” Mercè Boada Rovira, M.D., Ph.D.
“Novel Therapeutic Approaches to Prevent and Treat Tauopoathies,” Bess Frost, Ph.D.
Research Conference Day 1 at Briscoe Western Art Museum
Welcome and Opening Remarks
Sudha Seshadri, M.D.
Gladys E. Maestre, M.D., Ph.D.
Munro Cullum, Ph.D., ABPP
Scientific Session I: Personalized Care and Prevention
Plenary: “Technology to Advance Assessments and Interventions for Dementia” – Jeffrey Kaye, M.D.
“Implementation of Community-Based Programs to Support Family Caregivers” – Carole White, Ph.D., R.N., and Laura Novak, OTD, OTR, BCG
“Carino en su Casa, Palliative Care” – Neela K. Patel, M.D., M.P.H., CMD
“Cognitive Function in the Cameron County Hispanic Cohort” – Paul E. Schulz, M.D.
“The Economic Impact of Alzheimer’s on Latinos: An Overview & Call for Brain Health Equity” – Jason Resendez
Plenary: “An Epidemiological Approach to Identify Anti-Hypertensive Drugs Effective in Lowering Dementia Risk” – Lenore J. Launer, Ph.D., M.Sc.
“Risk Factors for Dementia: Implications for Prevention” – Mary Ganguli, M.D., M.P.H.
“Sleep and Dementia” – Andrée-Ann Baril, Ph.D.
Scientific Session II: Dementia in Hispanic Populations: Research
Chairs: Nicolas Musi, M.D., and Kyriakos S. Markides, Ph.D.
Plenary: “Alzheimer’s Prevention and Preparedness: Addressing Disparities” – Kristine Yaffe, M.D.
“Dementia Research in a Humanitarian Crisis Setting” – Gladys E. Maestre, M.D., Ph.D.
“Genome Research at Fundació ACE Project: Meta-GWAS with IGAP and UK Biobank Identifies Novel Loci for Alzheimer’s Disease” – Agustín Ruiz Laza, M.D., Ph.D.
Admixture and Aging: Perspectives from Two Elderly Samples from Sao Paulo, Brazil” – Michel S. Naslavsky, Ph.D.
“Alzheimer’s Genetics in Argentina: Evidence-Based Actions and Future Directions” – Laura Morelli, Ph.D., M.Sc.
“Studying Cognitive Aging in Mexico: Screening, Testing and Genetic Risk Factors in the Mexican Health and Aging Study” – Rafael Samper-Ternent, M.D., Ph.D.
“Healthcare Utilization by Older Mexican Americans with and without a Diagnosis of Alzheimer’s” – Brian Downer, Ph.D.
Scientific Session III: Mild Cognitive Impairment and Dementia Care and Research Around the World
Chairs: Cerise Elliott, Ph.D.
Plenary: “Inter-ethnic differences in prevalence of Cognitive Impairment” – Christopher Chen, BA, BMBCh, MRCP, FAMS, FRCPE
“Cognitive Resilience as the Basic Concept in Alzheimer’s Primary Care in Argentina” – Luis Ignacio Brusco, M.D.
“Dementia in Indigenous Africans: What We Know and What We Need to Know” – Rufus Akinyemi, Ph.D., M.Sc., MWACP, FMCP
“Understanding Heterogeneous Contributors to Dementia – The Canadian Perspective” – Mario Masellis, M.Sc., M.D., Ph.D., FRCPC
“A Nationwide Australian Perspective on Cognitive Aging and Dementia: An Overview of the Community-Based Healthy Brain Project” – Matthew Pase, Ph.D.
“Frailty, Nutrition and Cognition in Older Chileans” – Bárbara Angel Badillo, Ph.D.
Panel Discussion: Collaborative and Cross Disciplinary Research-Career Opportunities
Chairs: Bernard Fongang, Ph.D., Mario Gil, Ph.D.,Bernard Fongang, Ph.D. Pavel Rodriguez, M.D., Ph.D., Elizabeth Ochoa Thomas,
Cerise Elliott, Ph.D.
David Paydarfar, M.D.
Rebecca M. Edelmayer, Ph.D.
Research Conference Day 2 at Briscoe Western Art Museum
Scientific Session IV: Traumatic Brain Injury and Neurodegeneration
Chair: Byron Hepburn, M.D.
Plenary: Kristine Yaffe, M.D.
Scientific Session V: Imaging as a Tool to Explore Dementia Heterogeneity
Chairs: Carole Dufouil, Ph.D., and Mohamad Habes, Ph.D.
Plenary: “Brain Aging as a Useful Research Tool in the General Population,” Hans J. Grabe, M.D.
“Emerging New Techniques in Brain Imaging,” Peter T. Fox, M.D.
“Brain Structure in Neurodegeneration: A Precision Epidemiology Approach” Hieab Adams, M.D., Ph.D.
“Novel Biomarkers of Vascular and Degenerative Pathologies in the Aging Brain,” Saima Hilal, M.D., Ph.D.
“PET Imaging to Address Dementia Heterogeneity,” Joseph C. Masdeu, M.D., Ph.D.
“Data-Driven Subtyping of Brain Aging and Early Alzheimer’s Atrophy Patterns,” Mohamad Habes, Ph.D.
“Shades of White,” Pauline Maillard, Ph.D.
Scientific Session VI: Genetic and Omics Approaches to Understanding Dementias
Chair: Myriam Fornage, Ph.D., and Jenny Hsieh, Ph.D.
Plenary: “Genetics of Alzheimer’s Disease,” Jean-Charles Lambert, Ph.D.
“Non-coding RNAs and Cholinergic Pathways in the Healthy and Diseased Brain,” Hermona Soreq, Ph.D.
“Genetic Modulators of Disease Progression in Pre-Dementia Stages,” Alfredo Ramirez, M.D., Ph.D.
“Integration of Genomic and Transcriptomic Data Delivers Novel Candidate Genes for Alzheimer’s,”Maria Victoria Fernández Hernandez, Ph.D., M.Sc.
“Diagnostic Tools for Alzheimer’s using High Throughput Data,” Laura Ibanez, Ph.D.
“Functional Genomics in Alzheimer’s and Parkinson’s Disease,” Bruno A. Benitez, M.D.
Scientific Session VII: Cognitive Phenotyping for Early Diagnosis and Differential Diagnosis
Chair: A. Campbell Sullivan, Psy.D., ABPP-CN
“Regression-Based Normative Approaches,” S. Marc Testa, Ph.D., ABPP
“Global Neuropsychological Assessment in Research and Practice,” David J. Schretlen, Ph.D., ABPP
“Early Detection of Cognitive Decline,” Robin Hilsabeck, Ph.D., ABPP
Scientific Session VIII: Novel Approaches to Detection and Treatment of Dementias
Chairs: Mitzi Gonzales, Ph.D., ABPP-CN, and Robert Clark, M.D., MACP
Plenary: “An Overview of Promising New Approaches to Preventing and Treating Dementias,” Sudha
Seshadri, M.D.
“Use of Unsupervised Online Cognitive Tests in Studies of Aging: Progress and Pitfalls,” Scott
Mackin, Ph.D.
“Gemfibrozil’s Effect on MicroRNA in Prodromal Alzheimer’s Disease,” Gregory A. Jicha, M.D., Ph.D.
“Applying the Geroscience Hypothesis to the Treatment of Alzheimer’s Disease,” Miranda Orr, Ph.D.
“Using Machine Learning to Identify Novel Drug Combinations for Alzheimer’s Treatment,” Thomas J. Anastasio, Ph.D.
“Altering Tau Splicing to Identify and Treat Tauopathies,” Kathleen M. Schoch, Ph.D.
